BioMarin
Trade BioMarin 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMRN
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307.
BMRN Key Statistics
Stock Snapshot
The current BioMarin(BMRN) stock price is $59.43, with a market capitalization of 11.42B. The stock trades at a price-to-earnings (P/E) ratio of 22.10.
As of 2026-01-01, BioMarin(BMRN) stock has fluctuated between $58.44 and $59.71. The current price stands at $59.43, placing the stock +1.7% above today's low and -0.5% off the high.
The BioMarin(BMRN)'s current trading volume is 1.36M, compared to an average daily volume of 3.91M.
During the past year, BioMarin(BMRN) stock moved between $50.76 at its lowest and $73.51 at its peak.
During the past year, BioMarin(BMRN) stock moved between $50.76 at its lowest and $73.51 at its peak.
BMRN News
Leerink Partners analyst Joseph Schwartz downgraded the rating on Amicus to a Hold on December 26, setting a price target of $14.50. Claim 70% Off TipRanks This...
Leerink analyst Joseph Schwartz downgraded Amicus (FOLD) to Market Perform from Outperform with a price target of $14.50, down from $17, following the recently...